Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties (Q35559623)

8 August 2017

title

Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties (English)

1 reference

8 August 2017

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0163-7827(03)00033-X

21 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0163-7827(03)00033-X

21 March 2024

S. M. Moghimi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14559067

21 March 2024

J. Szebeni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14559067

21 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14559067

21 March 2024

publication date

1 November 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S016378270300033X?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0163-7827(03)00033-X

https://api.elsevier.com/content/article/PII:S016378270300033X?httpAccept=text/plain

21 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0163-7827(03)00033-X

Progress in Lipid Research

21 March 2024

published in

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

page(s)

463-478

1 reference

Poloxamers and poloxamines in nanoparticle engineering and experimental medicine.

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Sterically stabilized liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Stabilization of substances in circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan-stimulated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Poloxamer-188 revisited: a potentially valuable immune modulator

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Recognition and clearance of methoxypoly(ethyleneglycol)2000-grafted liposomes by macrophages with enhanced phagocytic capacity. Implications in experimental and clinical oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Protein adsorption to polyethylene glycol modified liposomes from fibrinogen solution and from plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Long-circulating (sterically stabilized) liposomes for targeted drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Influence of cholesterol on the association of plasma proteins with liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Influence of block copolymers on the adsorption of plasma proteins to microspheres.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Competition between adsorbed fibrinogen and high-molecular-weight kininogen on solid surfaces incubated in human plasma (the Vroman effect): influence of solid surface wettability

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Adsorption kinetics of protein mixtures. A tentative explanation of the Vroman effect.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Sch-28080 depletes intracellular ATP selectively in mIMCD-3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Interactions of IgM ABO antibodies and complement with methoxy-PEG-modified human RBCs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Ligand-receptor interactions in the phagocytosis of virulent Streptococcus pneumoniae by polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Primate erythrocyte-immune complex-clearing mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Structural and metabolic consequences of liposome-lipoprotein interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Host factors influencing the preferential localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Group II phospholipase A2 is increased in peritoneal and pleural effusions in patients with various types of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Increase in phospholipase A2 activity towards lipopolymer-containing liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Phospholipase A(2) activity towards vesicles of DPPC and DMPC-DSPC containing small amounts of SMPC.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Secreted phospholipase A(2) as a new enzymatic trigger mechanism for localised liposomal drug release and absorption in diseased tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Growth inhibition of human mammary carcinoma by liposomal hexadecylphosphocholine: Participation of activated macrophages in the antitumor mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Therapeutic synthetic polymers: a game of Russian roulette?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

CRL-1072 enhances antimycobacterial activity of human macrophages through interleukin-8

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Intestinal permeability to polyethyleneglycol and sugars: a re-evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2803%2900033-X

7 January 2021

Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers

1 reference

https://api.crossref.org/works/10.1016/S0163-7827(03)00033-X

21 March 2024

Identifiers

DOI

1 reference

8 August 2017

1 reference